Exosomal miRNAs as Potential Biomarkers for Preeclampsia: miR-1283 Has the Highest Expression, while miR-152-3p Has the Lowest Expression
Abstract
BACKGROUND: Preeclampsia management is necessary, as it is one of the leading causes of death during pregnancy. Exosomal microRNAs (miRNAs) can serve as biomarkers for early detection, diagnosis, and prognosis of preeclampsia. NanoStrings is an effective method for identifying exosomal miRNA due to their high sensitivity and ability to work with small amounts of miRNA; however, the analysis using this method for determining preeclampsia biomarker is still limited. Therefore, this study was conducted to utilize the NanoStrings method in identifying preeclampsia biomarkers related to its underlying pathophysiology.
METHODS: This study involved 12 pregnant women at 20–40 weeks of gestation, including 6 preeclampsia women and 6 normotension women. The miRNAs from plasma exosomes were processed using NanoStrings method with NanoString nCounter SPRINT Profiler. Enrichment analysis of The Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathways were performed to examine the pathophysiological pathways of preeclampsia, using the DIANA–miRPath v3.0.
RESULTS: Forty-eight miRNAs were downregulated and 7 were upregulated (miR-1283, miR-613, miR-520a-3p, miR-3185, miR-556-3p, miR-1973, and miR-598-3p) in women with preeclampsia. The highest expression was observed in miR-1283 (log fold-change: 3.69) and the most lowest expression was in miR-152-3p (log fold-change: 1.41). Enrichment analysis showed that the most upregulated miRNAs pathways was estrogen signaling pathway, and the most downregulated was Hippo signaling pathways.
CONCLUSION: miR-1283 has the highest expression, while and miR-152-3p has the lowest expression in preeclampsia women. These miRNAs are shown to be linked to specific pathways, shedding light on the pathophysiology of preeclampsia, and may serve as promising biomarkers.
KEYWORDS: exosomes, biomarker, miRNAs, pathophysiology, preeclampsia, pregnancy
Full Text:
PDFReferences
Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das Trisha A, et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021; 11(1): 21339, CrossRef.
Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia 2022. Jakarta: Kementerian Kesehatan Republik Indonesia; 2023, article.
Östling H, Lodefalk M, Backman H, Kruse R. Global microRNA and protein expression in human term placenta. Front Med. 2022; 9: 952827, CrossRef.
Kolkova Z, Holubekova V, Grendar M, Nachajova M, Zubor P, Pribulova T, et al. Association of circulating mirna expression with preeclampsia, its onset, and severity. Diagnostics. 20211; 11(3): 476, CrossRef.
Jairajpuri DS, Malalla ZH, Sarray S, Mahmood N. Analysis of differential expression of hypoxia-inducible microRNA-210 gene targets in mild and severe preeclamptic patients. Noncoding RNA Res. 2021; 6(1): 51-7, CrossRef.
Li H, Ouyang Y, Sadovsky E, Parks WT, Chu T, Sadovsky Y. Unique microRNA signals in plasma exosomes from pregnancies complicated by preeclampsia. Hypertension. 2020; 75(3): 762-71, CrossRef.
Xu P, Ma Y, Wu H, Wang YL. Placenta-derived microRNAs in the pathophysiology of human pregnancy. Front Cell Dev Biol. 2021; 9: 646326, CrossRef.
Youssef HMG, Marei ES. Association of microRNA-210 and microRNA-155 with severity of preeclampsia. Pregnancy Hypertens. 2019; 17: 49-53, CrossRef.
Pillay P, Vatish M, Duarte R, Moodley J, Mackraj I. Exosomal microRNA profiling in early and late onset preeclamptic pregnant women reflects pathophysiology. Int J Nanomedicine. 2019; 14: 5637-57, CrossRef.
Foye C, Yan IK, David W, Shukla N, Habboush Y, Chase L, et al. Comparison of miRNA quantitation by Nanostring in serum and plasma samples. PLoS One. 2017; 12(12): e0189165, CrossRef.
Bracht JWP, Gimenez-Capitan A, Huang CY, Potie N, Pedraz-Valdunciel C, Warren S, et al. Analysis of extracellular vesicle mRNA derived from plasma using the nCounter platform. Sci Rep. 2021; 11(1): 3712, CrossRef.
Matshazi DM, Weale CJ, Erasmus RT, Kengne AP, Davids SFG, Raghubeer S, et al. Circulating levels of microRNAs associated with hypertension: A cross-sectional study in male and female South African participants. Front Genet. 2021; 12: 710438, CrossRef.
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet. 2019; 145(S1): 1-33, CrossRef.
Légaré C, Clément AA, Desgagné V, Thibeault K, White F, Guay SP, et al. Human plasma pregnancy-associated miRNAs and their temporal variation within the first trimester of pregnancy. Reprod Biol Endocrinol. 2022; 20(1): 14, CrossRef.
Liu S, Xie X, Lei H, Zou B, Xie L. Identification of key circrnas/lncRNAs/miRNAs/ mRNAs and pathways in preeclampsia using bioinformatics analysis. Med Sci Monit. 2019: 25: 1679-93, CrossRef.
He L, Yuan J, Xu Q, Chen R, Chen L, Fang M. miRNA-1283 regulates the PERK/ATF4 pathway in vascular injury by targeting ATF4. PLoS One. 2016; 11(8): e0159171, CrossRef.
Chen H, Zhang Y, Su H, Shi H, Xiong Q, Su Z. Overexpression of mir-1283 inhibits cell proliferation and invasion of glioma cells by targeting atf4. Oncol Res. 2019; 27(3): 325-34, CrossRef.
Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. J Immun. 2010; 185(11): 6413-9, CrossRef.
Lee CL, Veerbeek JHW, Rana TK, van Rijn BB, Burton GJ, Yung HW. Role of endoplasmic reticulum stress in proinflammatory cytokine-mediated inhibition of trophoblast invasion in placenta-related complications of pregnancy. Am J Pathol. 2019; 189(2): 467-78, CrossRef.
Wang Q, Xie X, Li H, Hao S. Discovery of microRNA expression profiles involved in regulating TGF-β2 expression in the tears of dry eye patients. Ann Clin Biochem. 2020; 57(6): 420-8, CrossRef.
Prijanti AR, Oktavia NT, Iswanti FC, Mudjihartini N, Purwosunu Y. Increase in transforming growth factor-β did not affect trombospondin1 in preeclampsia placentas. Turk J Obstet Gynecol. 2023; 20(1): 22-8, CrossRef.
Yusrawati, Aidina, D, Yerizel, E. Comparison of transforming growth factor-beta 1 concentration in preeclampsia and normal pregnancy women. Indones Biomed J. 2017; (9)1: 49-52, CrossRef.
Yu X, Wang W. Tumor suppressor microRNA-613 inhibits glioma cell proliferation, invasion and angiogenesis by targeting vascular endothelial growth factor A. Mol Med Rep. 2017; 16(5): 6729-35, CrossRef.
Hu J, Liu L, Gong Y, Zhang L, Gan X, Luo X, et al. Linc02527 promoted autophagy in Intrahepatic cholestasis of pregnancy. Cell Death Dis. 2018; 9(10): 979, CrossRef.
Zbucka-Kretowska M, Niemira M, Paczkowska-Abdulsalam M, Bielska A, Szalkowska A, Parfieniuk E, et al. Prenatal circulating microRNA signatures of foetal Down syndrome. Sci Rep. 2019; 9(1): 2394, CrossRef.
Fomicheva KA, Knyazev EN, Mal'tseva DV. hsa-miR-1973 microRNA is significantly and differentially expressed in MDA-MB-231 cells of breast adenocarcinoma and xenografts derived from the tumor. Bull Exp Biol Med. 2017; 163(5): 660-2, CrossRef.
Insenser M, Tobar A, Quiñones S, Blasco F, M.A. MG, Luque-Ramírez M, et al. Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers. Hum Reprod. 2023; 38(5): 951-60, CrossRef.
Jairajpuri DS, Malalla ZH, Mahmood N, Almawi WY. Circulating microRNA expression as predictor of preeclampsia and its severity. Gene. 2017; 627: 543-8, CrossRef.
Ura B, Feriotto G, Monasta L, Bilel S, Zweyer M, Celeghini C. Potential role of circulating microRNAs as early markers of preeclampsia. Taiwan J Obstet Gynecol . 2014; 53(2): 232-4, CrossRef.
Zhu X ming, Han T, Wang X hong, Li Y hong, Yang H guang, Luo Y ning, et al. Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells. Am J Obstet Gynecol. 2010; 202(6): 592.e1-592.e7, CrossRef.
Manaster I, Goldman-Wohl D, Greenfield C, Nachmani D, Tsukerman P, Hamani Y, et al. MiRNA-mediated control of HLA-G expression and function. PLoS One. 2012; 7(3): e33395, CrossRef.
Zhang W, Wu Q, Su J, Wang W, Zhao X, Cao P. Circulating miRNAs as epigenetic mediators of periodontitis and preeclampsia association. Dis Markers. 2022: 2022: 2771492, CrossRef.
Zhang L, Yuan JM, Zhao R, Wang LM, Tu ZB. Correlation of MiR-152 expression with VEGF expression in placental tissue of preeclampsia rat and its influence on apoptosis of trophoblast cells. Eur Rev Med Pharmacol Sci. 2019; 23(9): 3553-60, CrossRef.
Iqbal MJ, Hadiati DR, Heriyanto DS. Bax mRNA expression as a potential biomarker of placental apoptosis in early-onset preeclampsia. Indones Biomed J. 2023; (15)3: 262-8, CrossRef.
Chen Y, Song YX, Wang ZN. The microRNA-148/152 family: Multi-faceted players. Mol Cancer. 2013; 12(1): 43, CrossRef.
Cheng JC, Fang L, Li Y, Thakur A, Hoodless PA, Guo Y, et al. G protein-coupled estrogen receptor stimulates human trophoblast cell invasion via YAP-mediated ANGPTL4 expression. Commun Biol. 2021; 4(1): 1285, CrossRef.
Shu C, Han S, Xu P, Wang Y, Cheng T, Hu C. Estrogen and preeclampsia: Potential of estrogens as therapeutic agents in preeclampsia. Drug Des Devel Ther. 2021: 15: 2543-50, CrossRef.
Karmia HR, Afriwardi, Ali H, Mose JC, Yusrawati. The correlation of L-citrulline levels with blood pressure in severe preeclampsia, Indones Biomed J. 2020; 12(1): 15-8, CrossRef.
Wang W, Zhang W, Chen L, Wu X, Gu J, Yang F, et al. Identification of differentially expressed miRNAs in plasma exosomes from patients with early-onset pre-eclampsia using next generation sequencing. Heliyon. 2024; 10(3): e24543, CrossRef.
Liu R, Wei C, Ma Q, Wang W. Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population. Pregnancy Hypertens. 2020; 19: 1-10, CrossRef.
DOI: https://doi.org/10.18585/inabj.v16i4.3197
Copyright (c) 2024 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
